| Cardiovascular Health and Disease Prevention | Lifetime | 23 | SE 2 | 99.77 |
| Blood Pressure and Hypertension Studies | Lifetime | 65 | SE 2 | 99.68 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 60 | SE 1 | 99.67 |
| Birth, Development, and Health | Lifetime | 234 | SE 6 | 99.15 |
| Diabetes Treatment and Management | Lifetime | 185 | SE 3 | 99.24 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 48 | SE 2 | 98.63 |
| Diet and metabolism studies | Lifetime | 648 | SE 22 | 98.87 |
| Metabolism, Diabetes, and Cancer | Lifetime | 322 | SE 10 | 98.71 |
| Cardiovascular Function and Risk Factors | Lifetime | 639 | SE 12 | 98.89 |
| Nutritional Studies and Diet | Lifetime | 350 | SE 9 | 98.73 |
| Cardiovascular Disease and Adiposity | Lifetime | 330 | SE 9 | 98.25 |
| Diabetes Management and Research | Lifetime | 407 | SE 12 | 98.54 |
| Heart Rate Variability and Autonomic Control | Lifetime | 689 | SE 17 | 97.88 |
| Cardiovascular Health and Risk Factors | Lifetime | 166 | SE 1 | 97.65 |
| Sodium Intake and Health | Lifetime | 124 | SE 1 | 97.83 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 881 | SE 25 | 96.57 |
| Telomeres, Telomerase, and Senescence | Lifetime | 408 | SE 5 | 93.96 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 757 | SE 12 | 93.96 |
| Diabetes Management and Education | Lifetime | 866 | SE 16 | 93.02 |
| Nutrition, Genetics, and Disease | Lifetime | 955 | SE 16 | 91.37 |
| Health, Environment, Cognitive Aging | Lifetime | 710 | SE 24 | 91.91 |
| Social and Educational Sciences | Lifetime | 874 | SE 634 | 90.71 |
| Sex and Gender in Healthcare | Lifetime | 950 | SE 16 | 67.74 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 26 | SE 2 | 98.28 |
| Birth, Development, and Health | 2021-2025 | 236 | SE 5 | 95.97 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 281 | SE 5 | 95.47 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 898 | SE 11 | 94.50 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 767 | SE 11 | 86.24 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 1,000 | SE 17 | 80.97 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 492 | SE 10 | 76.02 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 504 | SE 8 | 74.52 |
